Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

363
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
363
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

495
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
495
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

1.1K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.1K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.2K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

515
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
515
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating the antimicrobial efficacy of two aerosolized hydrogen peroxide fumigation cycles for biological safety cabinet decontamination.

Journal of applied microbiology·2026
Same author

New measurements of the half-life of <sup>225</sup>Ac at the NPL and IRA.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2026
Same author

Metformin on the Presence of COVID-19 Symptoms 6 Months after Infection: The ACTIV-6 Randomized Clinical Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Fluid Management of Acute Heart Failure With the Reprieve System: The Randomized Controlled FASTR Trial.

JACC. Heart failure·2026
Same author

Utility of point-of-care platelet aggregation testing for transfusion prediction.

Scientific reports·2026
Same author

Atomically thin gold embedded in inkjet-printed PVA hydrogels: flexible catalysts for ambient phenol degradation.

Nanoscale advances·2026

Related Experiment Video

Updated: Feb 14, 2026

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
07:41

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

Published on: March 17, 2022

3.4K

Optimizing Hypertensive Acute Heart Failure Management with Afterload Reduction.

Sean Collins1, Jennifer Martindale2

  • 1Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. sean.collins@vanderbilt.edu.

Current Hypertension Reports
|February 26, 2018
PubMed
Summary

Hypertensive acute heart failure (AHF) management may prioritize vasodilators over diuretics, as vascular changes, not just volume overload, drive symptoms. Further research is needed to confirm the efficacy of vasodilator therapies.

Keywords:
Acute heart failure heart failureEmergency departmentHypertensionVasodilators

More Related Videos

Magnetic Adjustment of Afterload in Engineered Heart Tissues
09:40

Magnetic Adjustment of Afterload in Engineered Heart Tissues

Published on: May 5, 2020

6.3K
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.2K

Related Experiment Videos

Last Updated: Feb 14, 2026

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
07:41

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

Published on: March 17, 2022

3.4K
Magnetic Adjustment of Afterload in Engineered Heart Tissues
09:40

Magnetic Adjustment of Afterload in Engineered Heart Tissues

Published on: May 5, 2020

6.3K
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.2K

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pharmacology

Background:

  • Acute heart failure (AHF) management traditionally focuses on diuretic-induced volume removal.
  • Understanding of AHF pathophysiology and diverse presentations has advanced.
  • Hypertensive AHF presents unique challenges distinct from other AHF phenotypes.

Purpose of the Study:

  • To review the pathophysiology of hypertensive acute heart failure (AHF).
  • To evaluate current and emerging therapies targeting hypertensive AHF mechanisms.
  • To challenge the traditional volume-centric approach in hypertensive AHF.

Main Methods:

  • This is a narrative review.
  • Literature search on pathophysiology and treatment of hypertensive AHF.
  • Appraisal of existing evidence for vasodilator and diuretic therapies.

Main Results:

  • Vascular redistribution, not solely volume overload, may elevate cardiac filling pressures in hypertensive AHF.
  • Vasodilators are proposed as the primary treatment, with diuretics reserved for persistent congestion.
  • High-dose intravenous nitroglycerin shows promise for rapid pulmonary decongestion.

Conclusions:

  • Current evidence for vasodilator therapies in hypertensive AHF is limited by study design and outcome data.
  • Further targeted research is essential before incorporating vasodilators into treatment guidelines.
  • A shift towards mechanism-based therapy, prioritizing vasodilators, is suggested for hypertensive AHF.